Stocks
Novartis (NVS) ROE US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 35.5% | 11.7% | 11.7% | 11.7% | 31.8% | 40.6% | ||
| Changes by years, y/y, % | 0pp | -24pp | 0pp | 0pp | +20pp | +14.7% | |||
Novartis. ROE, %
Novartis. ROE, changes, pp
Novartis (NVS) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | 20.5% | 31.8% | 38.4% | 38.8% | 40.6% | 40.6% | |
| Changes by years, y/y, % | -15pp | +20pp | +25pp | +24pp | +20pp | |||
| Changes by quarters, q/q, % | +6pp | +11pp | +7pp | +0pp | +2pp | |||
